Axonics Modulation Technologies Inc at Barclays Global Healthcare Conference Transcript
Joining us here for the next session at the Barclays Global Healthcare Conference. I'm Kristen Stewart, the medical supplies and device analyst. It is my pleasure to have Axonics here to talk about their technology and their program, their recent IPO in the MedTech space. So a newer entry here into the public domain. With us we have Dan Dearen, the company's CFO. We did have a little bit of a schedule change as Ray was unavailable. So Ray, we miss you, hope you're doing well. But Dan, without further ado, I'll turn it over to you.
Thank you very much. Thank you for having us. Thanks to Barclays, we have a long-standing relationship with the firm. As she mentioned, I'm Dan Dearen, I'm the President, Cofounder and Chief Financial Officer of the company, and Ray sends his regards. It's a pleasure to be here today to talk to you about Axonics and our neuromodulation system to treat chronic overactive bladder.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |